155 related articles for article (PubMed ID: 1653073)
21. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
Renesto P; Balloy V; Chignard M
Eur J Pharmacol; 1993 Aug; 248(2):151-5. PubMed ID: 8223961
[TBL] [Abstract][Full Text] [Related]
22. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
23. Effect of single oral administrations of non steroidal antiinflammatory drugs to healthy volunteers on arachidonic acid metabolism in peripheral polymorphonuclear and mononuclear leukocytes.
Colli S; Caruso D; Tremoli E; Stragliotto E; Morazzoni G; Galli G
Prostaglandins Leukot Essent Fatty Acids; 1988 Dec; 34(3):167-74. PubMed ID: 2851838
[TBL] [Abstract][Full Text] [Related]
24. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
Rajtar G; Marchi E; de Gaetano G; Cerletti C
Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages.
Shindo K; Machida M; Hirai Y; Fukumura M
Prostaglandins Leukot Essent Fatty Acids; 1997 Dec; 57(6):561-6. PubMed ID: 9431823
[TBL] [Abstract][Full Text] [Related]
26. Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro.
Villanueva M; Heckenberger R; Strobach H; Palmér M; Schrör K
Br J Clin Pharmacol; 1993 Mar; 35(3):235-42. PubMed ID: 8385973
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion.
Evangelista V; Piccardoni P; White JG; de Gaetano G; Cerletti C
Blood; 1993 Jun; 81(11):2947-57. PubMed ID: 7684621
[TBL] [Abstract][Full Text] [Related]
28. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
Evangelista V; Piccardoni P; de Gaetano G; Cerletti C
Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406
[TBL] [Abstract][Full Text] [Related]
29. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor.
Lin CN; Lee TH; Hsu MF; Wang JP; Ko FN; Teng CM
J Pharm Pharmacol; 1997 May; 49(5):530-6. PubMed ID: 9178190
[TBL] [Abstract][Full Text] [Related]
30. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
Zatta A; Prosdocimi M; Bazzoni G; Dejana E; Del Maschio A
Eur J Pharmacol; 1991 May; 198(1):97-100. PubMed ID: 1833211
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G.
Evangelista V; Piccardoni P; Maugeri N; De Gaetano G; Cerletti C
Eur J Pharmacol; 1992 Jun; 216(3):401-5. PubMed ID: 1425930
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
[TBL] [Abstract][Full Text] [Related]
33. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
[TBL] [Abstract][Full Text] [Related]
34. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
35. Stimulated elastase release from human leukocytes: influence of anti-asthmatic, anti-inflammatory and calcium antagonist drugs in vitro.
Werner U; Seitz O; Szelenyi I
Agents Actions; 1993; 38 Spec No():C112-4. PubMed ID: 8100381
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
Zhou W; Javors MA; Olson MS
J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
38. Synergism between interleukin-8 and tumor necrosis factor-alpha for neutrophil-mediated platelet activation.
Si Tahar M; Renesto P; Balloy V; Chignard M
Eur Cytokine Netw; 1994; 5(5):455-60. PubMed ID: 7880976
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of copper-aspirin complex on platelet aggregation.
Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of receptor-mediated platelet activation by nedocromil sodium.
Roth M; Solèr M; Lefkowitz H; Emmons LR; Anstine D; Hornung M; Perruchoud AP
J Allergy Clin Immunol; 1993 Jun; 91(6):1217-25. PubMed ID: 8389778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
